GlobeNewswire PharmaOriginal article
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
ConferenceXDEMVYPositive
AI Analysis
Summary
Tarsus Pharmaceuticals announced it will present 11 abstracts on XDEMVY and related indications at the American Academy of Optometry 2026 Annual Meeting in Anaheim, California.
Importance:3/10
Sentiment:
0.30
conference presentationXDEMVYdemodex blepharitisocular rosaceareal-world dataAAOpt
Related Companies
Read the original article
Published by GlobeNewswire Pharma on September 29, 2026 12:30 PM